GRI

AIFA redefines the criteria for awarding the “innovativeness status” to medicines

News Healthcare & Pharma Consultations
Date: 14th Jul, 2025 Source: Italian Medicines Agency (AIFA) Country: Italy Original Source

Brief

On 14/07/2025, the Italian Medicines Agency (AIFA) issued an update regarding AIFA redefines the criteria for awarding the "innovativeness status" to medicines. The new rules aim to promote innovative medicines in areas with real therapeutic needs, while ensuring the sustainability of the healthcare system and supporting research and development in Italy.

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
AIFA 2025 call for proposals for independent research on rare diseases: 100 projects submitted, for a total funding of €17.8 million
Date: 25th Jul, 2025 Source: Italian Medicines Agency (AIFA) Country: Italy
News Healthcare & Pharma Reports
Regional Assessment of Offshore Oil and Gas Exploratory Drilling East of Newfoundland and Labrador – Public Comments Invited on the Draft Follow-up Program Report for 2024-2025
Date: 25th Aug, 2025 Source: Canadian Environmental Assessment Agency Country: Canada
News Environment Consultations
Greenlight Electricity Centre Project – Public Comments Invited and Information Sessions on the Summary of the Initial Project Description
Date: 11th Aug, 2025 Source: Canadian Environmental Assessment Agency Country: Canada
News Environment Consultations

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales